Adage Capital Partners’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
100,912
+50,000
| +98% | +$807K | ﹤0.01% | 774 |
|
|
2025
Q1 | $1.07M | Hold |
50,912
| – | – | ﹤0.01% | 788 |
|
|
2024
Q4 | $1.27M | Buy |
+50,912
| New | +$1.27M | ﹤0.01% | 810 |
|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$300K | – | 895 |
|
|
2024
Q1 | $300K | Hold |
1,000
| – | – | ﹤0.01% | 812 |
|
|
2023
Q4 | $236K | Buy |
+1,000
| New | +$236K | ﹤0.01% | 788 |
|